You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Dow
Harvard Business School
Boehringer Ingelheim
Colorcon

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

TAMBOCOR Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Tambocor, and when can generic versions of Tambocor launch?

Tambocor is a drug marketed by Cnty Line Pharms and is included in one NDA.

The generic ingredient in TAMBOCOR is flecainide acetate. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.

US ANDA Litigation and Generic Entry Outlook for Tambocor

A generic version of TAMBOCOR was approved as flecainide acetate by AMNEAL PHARM on July 31st, 2001.

  Start Trial

Drug patent expirations by year for TAMBOCOR
Drug Prices for TAMBOCOR

See drug prices for TAMBOCOR

Recent Clinical Trials for TAMBOCOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chong Kun Dang Pharmaceutical Corp.Phase 4
Keimyung University Dongsan Medical CenterPhase 4
ZonMw: The Netherlands Organisation for Health Research and DevelopmentN/A

See all TAMBOCOR clinical trials

Paragraph IV (Patent) Challenges for TAMBOCOR
Tradename Dosage Ingredient NDA Submissiondate
TAMBOCOR TABLET;ORAL flecainide acetate 018830

US Patents and Regulatory Information for TAMBOCOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 AB RX Yes No   Start Trial   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 AB RX Yes No   Start Trial   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TAMBOCOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
McKesson
Harvard Business School
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.